Evidence map›Paper›PMID 33807548›Full record

ArticleInternational journal of molecular sciences2021

Mégane Collobert, Ozvan Bocher, Anaïs Le Nabec, Emmanuelle Génin, Claude Férec, Stéphanie Moisan

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Epigenetic regulation and chromatin organization in cystic fibrosis airways.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2026
    Review
  2. International journal of molecular sciences · 2025
    Article
  3. Tissue-Specific Regulation ofInternational journal of molecular sciences · 2023
    Review
  4. CFTR and Gastrointestinal Cancers: An Update.Journal of personalized medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mégane CollobertUniv. Brest, Inserm, EFS, UMR 1078, GGB, F-29200 Brest, France.ORCID 0000-0002-5396-8723
Ozvan BocherUniv. Brest, Inserm, EFS, UMR 1078, GGB, F-29200 Brest, France.ORCID 0000-0002-2467-9236
Anaïs Le NabecUniv. Brest, Inserm, EFS, UMR 1078, GGB, F-29200 Brest, France.
Emmanuelle GéninUniv. Brest, Inserm, EFS, UMR 1078, GGB, F-29200 Brest, France.ORCID 0000-0003-4117-2813
Claude FérecUniv. Brest, Inserm, EFS, UMR 1078, GGB, F-29200 Brest, France.
Stéphanie MoisanUniv. Brest, Inserm, EFS, UMR 1078, GGB, F-29200 Brest, France.ORCID 0000-0002-9745-1152
Inserm · FR

Funding

Association Vaincre la Mucoviscidose RF20200502633Gaétan Saleün association xRégion Bretagne x
6 · The paper itself

Abstract

About 8% of the human genome is covered with candidate

Indexed as

Caco-2 CellsCell Line, TumorChromatin ImmunoprecipitationCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorGene Expression RegulationGenes, ReporterHumansIntestinesIntronsTranscription FactorsCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorTranscription Factors3D structureCFTRcis-ruption disordersregulationtranscription factors

Identifiers

PMID33807548
PMCPMC7961337
OpenAlexW3135759808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.